All AbMole products are for research use only, cannot be used for human consumption.
Pimavanserin displays nanomolar potency as a 5-HT2A receptor inverse agonist, selectivity for 5-HT2A over 5-HT2C receptors, and no meaningful activity at any other G-protein coupled receptor. Pimavanserin demonstrates robust activity in preclinical models of schizophrenia and PDP, and do not worsen motoric symptoms, in contrast to the APDs tested. Pimavanserin showes highly significant benefits in the primary endpoint, the scale for assessment of positive symptoms-PD, a scale adapted for use in PDP. Pimavanserin is safe and well-tolerated with long-term use.
Eur J Neurosci. 2025 Mar 06;61(5):e70032.
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia
Pimavanserin purchased from AbMole
Neurotherapeutics. 2024 Feb 16;21(2):e00334.
Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis
Pimavanserin purchased from AbMole
 |
Source | Neurochem Res (2014). Figure 3. Pimavanserin |
| Method | immunofluorescence | |
| Cell Lines | animals with bilateral lesions of the SN | |
| Concentrations | ||
| Incubation Time | 24 h | |
| Results | Notably, pimavanserin not only reversed the psychosis-like behaviors, but did so without augmenting motor problems or blocking the ability of L-DOPA to improve motor behavior |
 |
Source | Neurochem Res (2014). Figure 2. Pimavanserin |
| Method | R-SATTM assays | |
| Cell Lines | NIH 3T3 cells | |
| Concentrations | 3 μM | |
| Incubation Time | ||
| Results | Pimavanserin is a potent, selective 5-HT2A inverse agonist, with selectivity over 5-HT2C receptors in binding and functional assays and little to no activity at other GPCRs in contrast to the available APDs |
| Cell Experiment | |
|---|---|
| Cell lines | NIH-3T3 cells |
| Preparation method | Receptor Selection and Amplification Technology. In brief, NIH-3T3 cells were grown to 80% confluence in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% bovine calf serum and 1% penicillin/streptomycin/glutamine. Cells were transfected in roller bottles for 18 h with the relevant G protein-coupled receptor gene and the gene for β-galactosidase. After transfection, cells were trypsinized, harvested, and frozen. Aliquots of frozen cell batches were thawed and tested for response to reference agonists and inverse agonists ensuring pharmacologically appropriate responses. To initiate an assay, cells were thawed rapidly and prepared in DMEM contained 0.4% calf serum, 30% UltraCulture, and 1% penicillin/streptomycin/glutamine, and then they were added to half-area 96-well microtiter plates containing either test compounds or reference ligands. After 5 days in culture, media were removed from the wells, and the cells were incubated at room temperature in 200 μl of phosphate-buffered saline, pH 7.4, with 3.5 mM o-nitrophenyl-β-d-galactopyranoside and 0.5% Nonidet P-40. After 2 to 4 h, the plates were read at 420 nm on a plate-reader. |
| Concentrations | 0~10 μM |
| Incubation time | 5 days |
| Animal Experiment | |
|---|---|
| Animal models | DOI head-twitch experiments in rats and Non-Swiss albino mice |
| Formulation | 0.9% saline |
| Dosages | 1, 3 or 10 mg/kg |
| Administration | s.c. or p.o. |
| Molecular Weight | 427.55 |
| Formula | C25H34FN3O2 |
| CAS Number | 706779-91-1 |
| Solubility (25°C) | DMSO 45 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related 5-HT Receptor Products |
|---|
| Granisetron hydrochloride
Granisetron hydrochloride is a potent and selective 5-HT3 receptor antagonist that possesses potent antiemetic activity. |
| Sumatriptan succinate
Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with Kis of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for the research of migraine headache. |
| Vortioxetine hydrobromide
Vortioxetine hydrobromide (Lu AA21004) is a 5-HT3, 5-HT7 and 5-HT1D receptor antagonist, a 5-HT1B receptor partial agonist, a 5-HT1A receptor agonist and a 5-HT transporter (5-HTT) inhibitor in vitro. |
| Prucalopride
Prucalopride is a potent, selective and specific serotonin 5-HT4 receptor agonist with enterokinetic properties. |
| (1S-cis)-Milnacipran Hydrochloride
(1S-cis)-Milnacipran hydrochloride is a selective norepinephrine and serotonin reuptake inhibitor approved for the management of fibromyalgia. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
